{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:22:23Z","timestamp":1759191743513,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.diabres.2022.109221","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T07:59:23Z","timestamp":1643615963000},"page":"109221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cClinical status and mortality in older adults with type 1 diabetes: Results from a public health system\u201d"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-1094","authenticated-orcid":false,"given":"Jesus","family":"Moreno-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Pin\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"del Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Calderon-Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Lopez Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-2039","authenticated-orcid":false,"given":"Jose-Ram\u00f3n","family":"Mu\u00f1oz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109221_b0005","doi-asserted-by":"crossref","unstructured":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995 Aug;44(8):968\u201383.","DOI":"10.2337\/diabetes.44.8.968"},{"key":"10.1016\/j.diabres.2022.109221_b0010","doi-asserted-by":"crossref","unstructured":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol. 1995 May 1;75(14):894\u2013903.","DOI":"10.1016\/S0002-9149(99)80683-3"},{"issue":"11","key":"10.1016\/j.diabres.2022.109221_b0015","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2337\/db11-1625","article-title":"Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort","volume":"61","author":"Miller","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.109221_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.diabres.2022.109221_b0025","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","article-title":"In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"53","author":"Orchard","year":"2010","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2022.109221_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/dc16-1213","article-title":"Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15\u201329 Years in Norway","volume":"40","author":"Gagnum","year":"2017","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2022.109221_b0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1464-5491.2003.01029.x","article-title":"Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)","volume":"20","author":"Bain","year":"2003","journal-title":"Diabet Med J Br Diabet Assoc."},{"issue":"8","key":"10.1016\/j.diabres.2022.109221_b0040","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/dc06-2222","article-title":"Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study","volume":"30","author":"Keenan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109221_b0045","unstructured":"Jk S, Ha K, Jd C, Bf A, Ej S, Dr S, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care [Internet]. 2011 Apr [cited 2021 Aug 12];34(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21447665\/."},{"issue":"9","key":"10.1016\/j.diabres.2022.109221_b0050","first-page":"539","article-title":"Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study","volume":"59","author":"Sastre","year":"2012","journal-title":"Endocrinol Nutr Organo Soc Espanola Endocrinol Nutr."},{"key":"10.1016\/j.diabres.2022.109221_b0055","article-title":"Control metab\u00f3lico y pautas de tratamiento en pacientes con diabetes tipo 1 en Castilla-La Mancha, 10 a\u00f1os despu\u00e9s. Estudio DIACAM1 2020","author":"Sastre","year":"2021","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"},{"issue":"5","key":"10.1016\/j.diabres.2022.109221_b0060","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc16-0102","article-title":"Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes","volume":"39","author":"Weisman","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.109221_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/dc17-1074","article-title":"Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison","volume":"41","author":"Weisman","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2022.109221_b0070","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2337\/dc20-2816","article-title":"Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes Study","volume":"44","author":"Harjutsalo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109221_b0075","doi-asserted-by":"crossref","first-page":"138817","DOI":"10.1016\/j.scitotenv.2020.138817","article-title":"Estimation of COVID-19 prevalence in Italy, Spain, and France","volume":"729","author":"Ceylan","year":"2020","journal-title":"Sci Total Environ."},{"issue":"1","key":"10.1016\/j.diabres.2022.109221_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.avdiab.2012.11.002","article-title":"Posibles causas de la infrautilizaci\u00f3n de la infusi\u00f3n subcut\u00e1nea continua de insulina en Espa\u00f1a","volume":"29","author":"Conget","year":"2013","journal-title":"Av En Diabetol."},{"key":"10.1016\/j.diabres.2022.109221_b0085","doi-asserted-by":"crossref","unstructured":"Bisio A, Gonder-Frederick L, McFadden R, Cher\u00f1avvsky D, Voelmle M, Pajewski M, et al. The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study. J Diabetes Sci Technol. 2021 Jan 15;1932296820986879.","DOI":"10.1177\/1932296820986879"},{"issue":"4","key":"10.1016\/j.diabres.2022.109221_b0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.diabres.2022.109221_b0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.diabres.2022.109221_b0100","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.diabres.2022.109221_b0105","first-page":"1196","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol."},{"issue":"2","key":"10.1016\/j.diabres.2022.109221_b0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2015.07.015","article-title":"Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes","volume":"22","author":"Bhatt","year":"2015","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.diabres.2022.109221_b0115","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/jc.2017-00589","article-title":"Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes","volume":"102","author":"Tinsley","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"10.1016\/j.diabres.2022.109221_b0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/dme.13266","article-title":"Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up","volume":"34","author":"Adamsson Eryd","year":"2017","journal-title":"Diabet Med J Br Diabet Assoc."},{"issue":"12","key":"10.1016\/j.diabres.2022.109221_b0125","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2337\/dc10-1170","article-title":"All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry","volume":"33","author":"Secrest","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2022.109221_b0130","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:19:31Z","timestamp":1759173571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272200033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":26,"alternative-id":["S016882272200033X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109221","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cClinical status and mortality in older adults with type 1 diabetes: Results from a public health system\u201d","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109221"}}